India to Myanmar: Leflunomide Export Trade Route
India has recorded 27 verified shipments of Leflunomide exported to Myanmar, representing a combined trade value of $2.1M USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $78.0K USD. The leading Indian exporter is TORRENT PHARMACEUTICALS LTD, which accounts for 49% of total export value with 9 shipments worth $1.0M USD. On the buying side, JDS CO LTD is the largest importer in Myanmar with $610.8K USD in purchases. The top 3 suppliers — TORRENT PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LTD , TORRENT PHARMACEUTICALS LIMITED — together control 92% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Myanmar Leflunomide corridor is one of India's established pharmaceutical export routes, with 27 shipments documented worth a combined $2.1M USD. The route is dominated by TORRENT PHARMACEUTICALS LTD, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's leflunomide manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $78.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with leflunomide's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 24.3%, placing it at rank #6 among India's top leflunomide export destinations globally.
On the import side, key buyers of Indian leflunomide in Myanmar include JDS CO LTD, JDS CO. LIMITED, JDS CO, LTD, and 12 others. JDS CO LTD is the single largest importer with 4 shipments valued at $610.8K USD.
Route Characteristics
- Average transit33 days
- Peak seasonQ3
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#6
- Annual growth+24.3%
- Demand growth+20.5%
- Regulatory ease74/100
Top 10 Indian Leflunomide Exporters to Myanmar
Showing top 10 of 6 Indian suppliers exporting Leflunomide to Myanmar, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LTD Avg $114.0K per shipment | 9 | $1.0M | 48.7% |
| 2 | TORRENT PHARMACEUTICALS LTD Avg $126.3K per shipment | 4 | $505.0K | 24.0% |
| 3 | TORRENT PHARMACEUTICALS LIMITED Avg $133.1K per shipment | 3 | $399.3K | 19.0% |
| 4 | KUSUM HEALTHCARE PRIVATE LIMITED Avg $16.0K per shipment | 7 | $111.7K | 5.3% |
| 5 | KUSUM HEALTHCARE PRIVATE LIMITED Avg $21.0K per shipment | 3 | $62.9K | 3.0% |
| 6 | ARAVIS PHARMACEUTICALS Avg $309 per shipment | 1 | $309 | 0.0% |
This table shows the top 10 of 6 Indian companies exporting leflunomide to Myanmar, ranked by total trade value. The listed exporters are: TORRENT PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LTD , TORRENT PHARMACEUTICALS LIMITED, KUSUM HEALTHCARE PRIVATE LIMITED, KUSUM HEALTHCARE PRIVATE LIMITED , ARAVIS PHARMACEUTICALS. TORRENT PHARMACEUTICALS LTD is the dominant supplier with 9 shipments worth $1.0M USD, giving it a 49% market share. The top 3 suppliers together account for 92% of the total trade value on this route.
Top 10 Leflunomide Importers in Myanmar
Showing top 10 of 15 known buyers in Myanmar receiving Leflunomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian leflunomide in Myanmar include JDS CO LTD, JDS CO. LIMITED, JDS CO, LTD, , JDS CO., LTD.., JDS CO., LTD.,, among 15 total buyers. The largest importer is JDS CO LTD, accounting for $610.8K USD across 4 shipments — representing 29% of all leflunomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | JDS CO LTD | 4 | $610.8K | 29.0% |
| 2 | JDS CO. LIMITED | 2 | $326.0K | 15.5% |
| 3 | JDS CO, LTD, | 2 | $305.1K | 14.5% |
| 4 | JDS CO., LTD.. | 2 | $178.5K | 8.5% |
| 5 | JDS CO., LTD., | 2 | $161.0K | 7.6% |
| 6 | JDS CO. LTD, | 1 | $100.9K | 4.8% |
| 7 | JDS CO LTD | 1 | $99.0K | 4.7% |
| 8 | JDS CO., LTD. | 1 | $82.0K | 3.9% |
| 9 | JDS CO, LTD, | 1 | $67.3K | 3.2% |
| 10 | J.D.S CO., LTD. | 3 | $62.9K | 3.0% |
Showing top 10 of 15 Leflunomide importers in Myanmar on this route.
Top 10 Leflunomide Formulations Imported by Myanmar
Showing top 10 of 20 product formulations shipped on the India to Myanmar Leflunomide route, ranked by trade value
Myanmar imports a wide range of leflunomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LEFRA 20 TABLET LEFLUNOMIDE 20MG NOS=1X5X10 TAB — accounts for $449.6K USD across 2 shipments. There are 20 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LEFRA 20 TABLET LEFLUNOMIDE 20MG NOS=1X5X10 TAB | 2 | $449.6K | 21.4% |
| 2 | OTHERS : LEFRA 20 TABLET (LEFLUNOMIDE20MG) - PACK SIZE 1x5x10 TABS | 2 | $326.0K | 15.5% |
| 3 | LEFRA 20 TABLET (LEFLUNOMIDE TABLET 20MG) (NOS=1X5X10 TAB) | 2 | $178.5K | 8.5% |
| 4 | LEFRA 20 TABLET (LEFLUNOMIDE 20MG) (NOS= | 1 | $155.0K | 7.4% |
| 5 | LEFRA 20 TABLET (LEFLUNOMIDE 20MG)(NOS=1 | 1 | $150.1K | 7.1% |
| 6 | LEFRA 20 TABLET (LEFLUNOMIDE 20MG) (NOS= 1X5X10 TAB) | 2 | $123.9K | 5.9% |
| 7 | LEFRA 20 TABLET (LEFLUNOMIDE TABLET 20MG) (NOS = 1X5X10 TAB) | 1 | $104.4K | 5.0% |
| 8 | LEFRA 20 TABLET (LEFLUNOMIDE 20MG) (NOS | 1 | $100.9K | 4.8% |
| 9 | OTHER - LEFRA 20 TABLET (LEFLUNOMIDE 20 | 1 | $99.0K | 4.7% |
| 10 | LEFRA 20 TABLET LEFLUNOMIDE TABLET 20MG NOS 1X5X10 TAB | 1 | $87.9K | 4.2% |
Showing top 10 of 20 Leflunomide formulations imported by Myanmar on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 73%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 4 shipments. Transit time averages 33 days by sea.
Market Dynamics
India's leflunomide exports to Myanmar are driven primarily by a handful of large-scale manufacturers. TORRENT PHARMACEUTICALS LTD with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — TORRENT PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LTD , TORRENT PHARMACEUTICALS LIMITED — together account for 92% of total trade value on this route. The average shipment value of $78.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as others : lefra 20 tablet (leflunomide20mg) - pack size 1x5x10 tabs and lefra 20 tablet (leflunomide tablet 20mg) (nos=1x5x10 tab), suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, JDS CO LTD is the largest importer with 4 shipments worth $610.8K USD — representing 29% of all leflunomide imports from India on this route. A total of 15 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.1M
- Avg. Shipment
- $78.0K
- Suppliers
- 6
- Buyers
- 15
- Transit (Sea)
- ~33 days
- Annual Growth
- +24.3%
Related Analysis
Other Leflunomide Routes
Unlock the Full India to Myanmar Leflunomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 27 shipments on this route.
Frequently Asked Questions — India to Myanmar Leflunomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Leflunomide to Myanmar?
The leading Indian exporters of Leflunomide to Myanmar are TORRENT PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LTD , TORRENT PHARMACEUTICALS LIMITED. TORRENT PHARMACEUTICALS LTD holds the largest market share at approximately 49% of total trade value on this route.
Q What is the total value of Leflunomide exports from India to Myanmar?
India exports Leflunomide to Myanmar worth approximately $2.1M USD across 27 recorded shipments. The average value per shipment is $78.0K USD.
Q Which ports does India use to ship Leflunomide to Myanmar?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 4 shipments. Indian exporters primarily use sea freight for this route, with 73% of shipments going by sea and 21% by air.
Q How long does shipping take from India to Myanmar for Leflunomide?
The average transit time for Leflunomide shipments from India to Myanmar is approximately 33 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Myanmar Leflunomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 24.3% with demand growth tracking at 20.5%. The route is ranked #6 among India's top Leflunomide export destinations globally.
Q How many suppliers are active on the India to Myanmar Leflunomide route?
There are currently 6 active Indian suppliers exporting Leflunomide to Myanmar. The market is moderately concentrated with TORRENT PHARMACEUTICALS LTD accounting for 49% of total shipment value.
Q Who are the main importers of Leflunomide from India in Myanmar?
The leading importers of Indian Leflunomide in Myanmar include JDS CO LTD, JDS CO. LIMITED, JDS CO, LTD, , JDS CO., LTD.., JDS CO., LTD.,. JDS CO LTD is the largest buyer with 4 shipments worth $610.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Myanmar export trade corridor identified from Indian Customs (DGFT) records for Leflunomide.
- 2.Supplier/Buyer Matching: 6 Indian exporters and 15 importers in Myanmar matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 27 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
27 Verified Shipments
6 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists